Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yosuke Ando is active.

Publication


Featured researches published by Yosuke Ando.


Oncology | 2016

Influence of R-CHOP Therapy on Immune System Restoration in Patients with B-Cell Lymphoma

Kaori Ito; Masataka Okamoto; Yoko Inaguma; Akinao Okamoto; Maiko Ando; Yosuke Ando; Masahiro Tsuge; Ayana Tomono; Yukiko Kakumae; Takahiro Hayashi; Shigeki Yamada; Nobuhiko Emi

Objective: To assess the immunosuppressive effect of R-CHOP in patients with B-cell lymphoma at 2 years. Methods: Parameters of humoral and cell-mediated immunity were assessed in 89 patients with diffuse large B-cell lymphoma or follicular lymphoma before and after 6-8 cycles of R-CHOP-14 or R-CHOP-21 regimen. Results: Data on pre- and posttreatment serum IgG (sIgG) levels were available for all 89 patients, while the corresponding data on serum CD20+, CD3+, CD4+, and CD8+ lymphocyte counts were available in only 43. Median sIgG levels significantly decreased from 1,221 mg/dl (baseline) to 733 mg/dl (after chemotherapy) (p < 0.001). Although CD20+ and CD4+ cell counts decreased (p < 0.001), no significant effect of chemotherapy on CD3+ and CD8+ cell counts was observed. CD20+ cell counts were restored to baseline levels at the 12-month follow-up. sIgG levels and CD4+ cell counts were not completely restored at 24 months, indicating a sustained immunosuppressive effect of R-CHOP in these patients. The incidence of infections over the 2-year period was 16.3-23.6%. Conclusion: The immunosuppressive effect of R-CHOP in newly diagnosed cases of B-cell lymphoma tends to persist for >2 years, although sIgG levels were restored more quickly than CD4+ cell counts.


Oncology | 2016

Contents Vol. 91, 2016

Cherif Akladios; Jean-Emmanuel Kurtz; Jean-Jacques Baldauf; Frédéric Marchal; Laure-Emilie Rebstock; Thierry Petit; Karolina Afors; Carole Mathelin; Lise Lecointre; Stéphanie Schrot-Sanyan; Vivek Subbiah; Oliver Holmes; Mariko Kobayashi; Masahiro Kobayashi; Fumitaka Suzuki; Hitomi Sezaki; Shunichiro Fujiyama; Yusuke Kawamura; Tetsuya Hosaka; Satoshi Saitoh; Yoshiyuki Suzuki; Yasuji Arase; Kenji Ikeda; Norio Akuta; Monica Lencioni; Enrico Vasile; Giulia Pasquini; Lorenzo Fornaro; Chiara Caparello; Caterina Vivaldi

A.B. Benson, Chicago, Ill. A. Chang, Singapore A.L. Cheng, Taipei J.F. Cleary, Madison, Wis. M. Dietel, Berlin P. Dufour, Strasbourg M.S. Ernstoff, Buffalo, N.Y. M.G. Fakih, Duarte, Calif. J.J. Grau, Barcelona H. Gronemeyer, Illkirch D.F. Hayes, Ann Arbor, Mich. C.S. Johnson, Buffalo, N.Y. M.J. Kelley, Durham, N.C. L. Kumar, New Delhi P.J. Loehrer, Indianapolis, Ind. J.R. Marshall, Buffalo, N.Y. S. Monfardini, Milan R. Nagler, Haifa R. Ohno, Nagoya B. Pestalozzi, Zurich H.M. Pinedo, Amsterdam E.A. Repasky, Buffalo, N.Y. A. Semczuk, Lublin E.F. Smit, Amsterdam C.N. Sternberg, Rome R. Stupp, Zurich M.S. Tallman, New York, N.Y. S. Tanaka, Hiroshima M. Tian, Houston, Tex. D.L. Trump, Buffalo, N.Y. T. Wiegel, Ulm W. Yasui, Hiroshima H. Zhang, Hangzhou City Editor-in-Chief


Oncology | 2015

Acknowledgement to the Reviewers

Cherif Akladios; Jean-Emmanuel Kurtz; Jean-Jacques Baldauf; Frédéric Marchal; Laure-Emilie Rebstock; Thierry Petit; Karolina Afors; Carole Mathelin; Lise Lecointre; Stéphanie Schrot-Sanyan; Vivek Subbiah; Oliver Holmes; Mariko Kobayashi; Masahiro Kobayashi; Fumitaka Suzuki; Hitomi Sezaki; Shunichiro Fujiyama; Yusuke Kawamura; Tetsuya Hosaka; Satoshi Saitoh; Yoshiyuki Suzuki; Yasuji Arase; Kenji Ikeda; Norio Akuta; Monica Lencioni; Enrico Vasile; Giulia Pasquini; Lorenzo Fornaro; Chiara Caparello; Caterina Vivaldi

www.karger.com/ocl Banke Agarwal, Saint Louis, Mo., USA Bharat B. Aggarwal, Houston, Tex., USA Jaffer A. Ajani, Houston, Tex., USA Salah-Eddin Al-Batram, Frankfurt a.M., Germany Roberto Angioli, Rome, Italy Jorge Aparicio, Valencia, Spain Carl Atkins, Albany, N.Y., USA Georges Azzi, Miami, Fla., USA Eishi Baba, Fukuoka, Japan Moo Jun Baek, Cheonan, Korea Lodovico Balducci, Tampa, Fla., USA Klaus H. Baumann, Marburg, Germany Wolf O. Bechstein, Frankfurt a.M., Germany Yves Bécouarn, Bordeaux, France Al B. Benson, Chicago, Ill., USA Patrick Boland, Buffalo, N.Y., USA Philip Bonomi, Chicago, Ill., USA Marius G. Bredell, Zumikon, Switzerland Fátima Carneiro, Porto, Portugal Yee Chao, Taipei, Taiwan Yao-Tseng Chen, New York, N.Y., USA Ann-Lii Cheng, Taipei, Taiwan Dennis S. Chi, New York, N.Y., USA James Cleary, Madison, Wis., USA Manola Comar, Trieste, Italy Renzo Corvò, Genoa, Italy Allan Covens, Toronto, Ont., Canada Paola Di Bonito, Rome, Italy Reinhard Dummer, Zurich, Switzerland Michael Duruisseaux, Grenoble, France Janice P. Dutcher, Bronx, N.Y., USA Monika Eichholzer, Zurich, Switzerland Bernhard J. Eigl, Vancouver, B.C., Canada Robert M. Eisele, Homburg, Germany Peter M. Ellis, Hamilton, Ont., Canada Günter Emons, Göttingen, Germany Nobuyuki Enomoto, Yamanashi, Japan Marwan G. Fakih, Duarte, Calif., USA Nicola Fazio, Milan, Italy Steven Feigenberg, Baltimore, Md., USA Clemens Feistritzer, Innsbruck, Austria Alexandra R. Fernandes, Caparica, Portugal Thiago Ferreira, Campinas, Brazil Petra Feyer, Berlin, Germany Ralph S. Freedman, Houston, Tex., USA César O. Freytes, San Antonio, Tex., USA Martin Früh, St. Gallen, Switzerland Masashi Fujii, Tokyo, Japan Val Gebski, Sydney, N.S.W., Australia Tarik Gheit, Lyon, France Alan M. Gillespie, Sheffield, UK Priscila Goncalves, Bethesda, Md., USA Juan-José Grau, Barcelona, Spain Frank Griesinger, Oldenburg, Germany Kathrin M. Gschwendtner, Freiburg, Germany Dominique Guenot, Strasbourg, France Stephan L. Haas, Stockholm, Sweden John D. Hainsworth, Nashville, Tenn., USA Shalaka Hampras, Tampa, Fla., USA Sheng-Po Hao, Taipei, Taiwan John H. Healey, New York, N.Y., USA Stephanie Hehlgans, Frankfurt a.M., Germany Masashi Hirooka, Toon, Ehime, Japan Wouter Hogendoorn, Rotterdam, The Netherlands Shigeo Horie, Tokyo, Japan Nadine Houédé, Nimes, France M.A. Huber, San Antonio, Tex., USA Jutta Hübner, Berlin, Germany Nuhad K. Ibrahim, Houston, Tex., USA Masafumi Ikeda, Chiba, Japan Misa Imai, Tokyo, Japan Takeshi Isobe, Izumo, Japan Namiki Izumi, Tokyo, Japan Long R. Jiao, London, UK Robin L. Jones, Seattle, Wash., USA Hrishi B. Joshi, Cardiff, UK Vassilos Karavassilis, Thessaloniki, Greece Shunsuke Kato, Tokyo, Japan Satoshi Kato, Morioka, Japan Nancy Kemeny, New York, N.Y., USA Hyung Jin Kim, Suwon, Korea Duck-Woo Kim, Seongnam, Korea Lee Su Kim, Ahnyang, Korea Yasushi Kojima, Shinjuku-ku, Japan Shigehiro Kokubu, Kawasaki, Japan Srinadh Komanduri, Chicago, Ill., USA Susan Krown, New York, N.Y., USA Takashi Kumada, Ogaki, Japan Takayasu Kurata, Osaka, Japan


Supportive Care in Cancer | 2016

Comparison between 5-day aprepitant and single-dose fosaprepitant meglumine for preventing nausea and vomiting induced by cisplatin-based chemotherapy

Yosuke Ando; Takahiro Hayashi; Kaori Ito; Eri Suzuki; Naoyuki Mine; Ayumi Miyamoto; Miyuki Oya; Hidezo Matsuda; Ami Isaji; Toru Nakanishi; Kazuyoshi Imaizumi; Tomoyuki Shibata; Tatsuyoshi Okada; Kazuo Sakurai; Kensei Naito; Ichiro Uyama; Kenji Kawada; Hiroshi Takahashi; Shigeki Yamada


Cancer Chemotherapy and Pharmacology | 2016

Effect of renal function on pemetrexed-induced haematotoxicity

Yosuke Ando; Takahiro Hayashi; Moeko Ujita; Sumie Murai; Hideki Ohta; Kaori Ito; Teppei Yamaguchi; Minori Funatsu; Yoshiaki Ikeda; Kazuyoshi Imaizumi; Kenji Kawada; Kimio Yasuda; Shigeki Yamada


Cancer Chemotherapy and Pharmacology | 2017

Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer

Hideki Ohta; Takahiro Hayashi; Sumie Murai; Hideyo Shiouchi; Yosuke Ando; Satomi Kumazawa; Kaori Ito; Yoshiaki Ikeda; Hiroshi Matsuoka; Kotaro Maeda; Kenji Kawada; Kimio Yasuda; Shigeki Yamada


Cancer Chemotherapy and Pharmacology | 2016

Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin lymphoma

Ayana Tomono; Kaori Ito; Takahiro Hayashi; Maiko Ando; Yosuke Ando; Masahiro Tsuge; Akinao Okamoto; Yoko Inaguma; Masataka Okamoto; Nobuhiko Emi; Shigeki Yamada


Annals of Oncology | 2015

O2-11-3Influence of rituximab(R) -fludarabine(F) and R-bendamustine(B) therapy on the immune system in relapsed lymphoma

Kaori Ito; Masataka Okamoto; Maiko Ando; Yosuke Ando; Eri Suzuki; Akinao Okamoto; Yoko Inaguma; Takahiro Hayashi; Shigeki Yamada; Nobuhiko Emi


Oncology | 2014

Front & Back Matter

Cherif Akladios; Jean-Emmanuel Kurtz; Jean-Jacques Baldauf; Frédéric Marchal; Laure-Emilie Rebstock; Thierry Petit; Karolina Afors; Carole Mathelin; Lise Lecointre; Stéphanie Schrot-Sanyan; Vivek Subbiah; Oliver Holmes; Mariko Kobayashi; Masahiro Kobayashi; Fumitaka Suzuki; Hitomi Sezaki; Shunichiro Fujiyama; Yusuke Kawamura; Tetsuya Hosaka; Satoshi Saitoh; Yoshiyuki Suzuki; Yasuji Arase; Kenji Ikeda; Norio Akuta; Monica Lencioni; Enrico Vasile; Giulia Pasquini; Lorenzo Fornaro; Chiara Caparello; Caterina Vivaldi


Annals of Oncology | 2014

P3-9-4IMPORTANCE OF BLOOD PRESSURE MONITORING IN COLORECTAL CANCER PATIENTS TREATED WITH BEVACIZUMAB: THE CURRENT SITUATION

Satomi Kumazawa; Hiroshi Matsuoka; Yosuke Ando; Maiko Ando; Yukiko Kakumae; Kaori Ito; Hideki Ohta; Shigeki Yamada; Kotaro Maeda

Collaboration


Dive into the Yosuke Ando's collaboration.

Top Co-Authors

Avatar

Kaori Ito

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar

Shigeki Yamada

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maiko Ando

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar

Akinao Okamoto

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar

Hideki Ohta

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nobuhiko Emi

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar

Yoko Inaguma

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge